Human Albumin 20% Behring, Low Salt 50ml - injection Albumin Human 20% - 20%/50ml 1 50ml Bottle(s) / 50ml Bottle CSL Behring Introduction: Human Albumin 20% Behring, Low Salt 50ml is used to treat blood volume loss. It works by replacing the body fluids lost due to excessive trauma, bleeding, surgery, or kidney dialysis. Thus, it is helpful in treating low blood albumin levels. Human Albumin 20% Behring, Low Salt 50ml must be administered under the supervision of a healthcare professional. You should not take it if you have any known allergy from this injection. Before taking it, inform the doctor you are suffering from any severe heart disease. Your doctor may check your blood pressure and ask you to get regular blood... Uses of Human Albumin 20% Behring, Low Salt 50ml: Nephrotic syndrome Side effects of Human Albumin 20% Behring, Low Salt 50ml: VomitingFlushing (sense of warmth in the face, ears, neck and trunk)FeverNauseaChillsHivesSlow heart rate How to use Human Albumin 20% Behring, Low Salt 50ml: Your doctor or nurse will give you this medicine. Kindly do not self-administer. How Human Albumin 20% Behring, Low Salt 50ml works: Human Albumin 20% Behring, Low Salt 50ml contains human albumin, a natural protein in blood. It works by replacing the blood or body fluids lost due to excessive bleeding, surgery, or kidney dialysis. What if you forget to take Human Albumin 20% Behring, Low Salt 50ml?: If you miss a dose of Human Albumin 20% Behring, Low Salt 50ml, please consult your doctor. Indication: Burns, Hypovolemia, Hypoalbuminemia, Hypoproteinaemia, Adult Respiratory Distress Syndrome, Nephrosis, Cardiopulmonary Bypass Surgery, Hemolytic Disease of the Newborn, Ovarian Hyperstimulation Syndrome, Acute hypovolaemic shock, Neonatal hyperbilirubinaemia Adult Dose: Adult: Initially, 25 g of albumin, adjusted according to patient's response. Usual rates of infusion: Up to 1-2 ml/minute (20% solution). Intravenous Hypoproteinaemia Adult: Up to 2 g/kg daily. Usual rates of infusion: Up to 1-2 ml/minute (20% solution). Special Populations: Volume admin and rate of infusion must always be individualised according to situation and response. Usual rates of infusion are up to 1-2 ml/min (20% soln). Child Dose: Child: Up to 1 g/kg, adjusted according to patient's response. Usual rates of infusion: Up to 1-2 ml/minute (20% solution). Intravenous Neonatal hyperbilirubinaemia Child: 1 g/kg of albumin before exchange transfusion. Usual rates of infusion: Up to 1-2 ml/minute (20% solution). Special Populations: Volume admin and rate of infusion must always be individualised according to situation and response. Usual rates of infusion are up to 1-2 ml/min (20% soln). Contraindication: Cardiac failure, severe anaemia, history of hypersensitivity, parenteral nutrition. Mode of Action: Human albumin increases intravascular oncotic pressure and causes movement of fluids from interstitial into intravascular space. Human albumin solutions are available in various concentrations. Solutions containing 5% human albumin are usually used in hypovolemic patients, whereas more concentrated 25% solutions are recommended in patients in whom fluid and sodium intake must be minimised e.g. patients with hypoproteinaemia or cerebral oedema or in paediatric patients. Precaution: Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation. Side Effect: Allergic reactions, nausea, vomiting, increased salivation, fever and chills; vascular overload, haemodilution and pulmonary oedema. Potentially Fatal: Anaphylactic shock. Pregnancy Category Note: Pregnancy category: C Lactation: Endogenous albumin found in breast milk; compatible Interaction: Albumin solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with albumin human replacement.